Core Viewpoint - President Trump's executive order to reschedule cannabis to Schedule 3 is considered a significant shift in federal cannabis policy, potentially alleviating the burdensome tax regime on American cannabis operators [1]. Financial Implications - The executive order may lead to the elimination of Section 280E of the Internal Revenue Code, which currently taxes legal cannabis operators as if they were narcotics traffickers, preventing them from deducting any business expenses [2][3]. - Rescheduling cannabis to Schedule 3 would allow U.S. companies to deduct standard operating costs, significantly improving their financial health and cash flow profiles [3]. Market Reaction - The cannabis industry is responding positively to the news, especially after a strong performance in 2025, where the AdvisorShares MSOS ETF outperformed the S&P 500 [4]. Investment Volatility - Despite the positive developments, the cannabis sector remains highly volatile, with many institutional investors hesitant due to past political inaction. A market "pop" is anticipated upon finalization of the rescheduling, but this is viewed as just the initial step in a longer reform process [5]. Remaining Challenges - Even with the potential rescheduling, U.S. cannabis companies still face hurdles, such as the inability to list on major exchanges like NASDAQ or NYSE, which is available to Canadian companies. Additionally, the industry is still awaiting "safe harbor" provisions for banking [6].

PRESIDENT WAS REALLY TALKING ABOUT >> HI, EVERYBODY. WE WANT TO >> HI, EVERYBODY. WE WANT TO TAKE YOU NOW TO WASHINGTON, TAKE YOU NOW TO WASHINGTON, WHERE THE PRESIDENT IS SIGNING WHERE THE PRESIDENT IS SIGNING AN EXECUTIVE ORDER EASING AN EXECUTIVE ORDER EASING RESTRICTIONS ON CANNABIS. HE IS RESTRICTIONS ON CANNABIS.HE IS TAKING QUESTIONS NOW IN THE TAKING QUESTIONS NOW IN THE OVAL OFFICE. LET'S L LISTEN IN. OVAL OFFICE.LET'S LISTEN IN. >> NOW. BRACING FOR THEIR >> NOW. BRACING FOR THEIR PREMIUMS TO SKYRO ...

Core Viewpoint - U.S. President Donald Trump plans to direct the U.S. Department of Justice to reclassify cannabis as a less dangerous drug, which could significantly impact the cannabis industry and consumers shopping at dispensaries [1] Group 1: Impact on Cannabis Classification - The reclassification of cannabis could lead to changes in legal status, potentially increasing accessibility for consumers [1] - A less dangerous classification may encourage more research and development in cannabis-related products [1] - This move could influence state-level regulations and the overall market dynamics of the cannabis industry [1] Group 2: Implications for Consumers - Consumers may experience a broader range of products available at dispensaries due to the reclassification [1] - The change could lead to lower prices and increased competition among cannabis retailers [1] - Enhanced consumer confidence in cannabis products may result from the new classification [1]

Regulatory Landscape - The executive order aims to expedite the reclassification of cannabis [1] - The order does not legalize cannabis at the federal level [1] - It intends to ease regulatory obstacles for studying the medical benefits of cannabis [1] News & Media Coverage - NBC News provides fact-based reporting, meaningful conversations, and powerful stories [1] - NBC News offers various platforms including broadcasts, streaming, podcasts, app, and website [1]

Core Insights - The Zacks Agriculture - Products industry is expected to benefit from stable food demand driven by population growth and consumer preferences for healthier options [1][4] - Innovative agricultural technologies like hydroponics and vertical farming are anticipated to be significant growth drivers for the industry [1][5] Industry Overview - The Zacks Agriculture - Products industry includes companies involved in storing agricultural commodities, distributing ingredients, and farming crops, livestock, and poultry products [3] - Companies in this sector also provide nutrients, advanced lighting systems, and accessories for hydroponic gardening, as well as innovative plant-based health products [3] Demand Trends - Global population is projected to reach 8.5 billion by 2030 and 9.7 billion by 2050, leading to a 50% increase in food demand [4] - Companies are investing in innovation to meet consumer demand for healthier food alternatives, enhancing product and market strategies [4] Technological Innovations - Hydroponics allows for controlled nutrient delivery and faster crop growth, making it popular in cannabis cultivation and vertical farming [5] - Vertical farming minimizes land and water usage, addressing environmental vulnerabilities and food production challenges [5] Cost Management - Industry players are facing rising costs in labor, packaging, and distribution, but have implemented cost-reduction actions to sustain margins [6] - Recent easing of feed prices may help companies engaged in animal products manage production costs [6] Industry Performance - The Zacks Agriculture - Products industry holds a Zacks Industry Rank of 99, placing it in the top 41% of 243 Zacks industries, indicating positive prospects [7][8] - Over the past 12 months, the industry has underperformed, with a decline of 11.9% compared to the S&P 500's increase of 17.9% [9] Valuation Metrics - The industry is currently trading at a trailing 12-month EV/EBITDA ratio of 10.17X, significantly lower than the S&P 500's 18.51X and the Basic Materials sector's 14.62X [12] Company Highlights - **Bunge Global S.A (BG)**: Recently completed a $34 billion merger with Viterra Ltd., enhancing its global agribusiness platform and expected to yield stable cash flows and synergies [14] - BG has a trailing four-quarter earnings surprise of 11.75% and a long-term estimated earnings growth of 5.13%, currently holding a Zacks Rank of 2 (Buy) [15] - **GrowGeneration (GRWG)**: Reported a 15.4% sequential net sales growth in Q3 2025, returning to positive adjusted EBITDA and improving gross margins [21] - GRWG's proprietary brands are expected to contribute significantly to revenue growth, with a focus on acquiring profitable hydroponic garden centers [21][22]

Core Viewpoint - The U.S. President is anticipated to sign an executive order to expedite the reclassification of cannabis, which could significantly impact the cannabis industry and its regulatory landscape [1] Group 1: Executive Order Impact - The executive order is expected to fast-track the reclassification process of cannabis, potentially leading to changes in its legal status and regulatory framework [1] - This move may open up new opportunities for investment and growth within the cannabis sector, as it could facilitate easier access to banking and financial services [1] Group 2: Industry Implications - The reclassification could lead to increased legitimacy for cannabis businesses, attracting more investors and enhancing market confidence [1] - A shift in cannabis classification may also influence state-level regulations and encourage further legalization efforts across the country [1]

Core Insights - Organigram Global Inc, Canada's leading recreational cannabis company, reported record financial results for the fourth quarter and fiscal year ending September 30, 2025, highlighting significant growth in revenue and market share [2][4]. Fiscal 2025 Financial Highlights - Gross revenue reached $403.0 million, a 63% increase year-over-year, while net revenue was $259.2 million, up 62% from the previous year [4][6]. - Adjusted EBITDA increased by 160% to $21.9 million, driven by higher recreational cannabis revenue and improved gross margins [4][6]. - The company maintained a 11.9% market share in the Canadian recreational cannabis market [4][6]. Fourth Quarter 2025 Financial Overview - In Q4, gross revenue was $123.3 million, a 76% increase year-over-year, with net revenue rising 79% to $80.1 million [4][6]. - Adjusted gross margin for Q4 was $30.6 million, representing 38% of net revenue, compared to 37% in Q4 Fiscal 2024 [4][6]. - The net loss for Q4 was $38.0 million, a significant increase from a loss of $5.4 million in the same quarter last year, primarily due to non-cash changes in fair value [4][6]. Strategic Initiatives and Acquisitions - The company expanded its capabilities through acquisitions, including Motif Labs Ltd., enhancing its extraction capabilities and market presence [2][4]. - Organigram launched its Fast Acting Soluble Technology (FAST) and entered the U.S. cannabinoid beverages market through the acquisition of Collective Project Limited [4][12]. - The company is focused on operational scale, intellectual property, and market access to support future growth [2][4]. International Growth - Record international revenue reached $26.3 million, a 173% increase year-over-year, reflecting the company's expanding global footprint [4][12]. - The company completed its EU-GMP audit and is awaiting certification confirmation, which will facilitate further international expansion [12][4]. Balance Sheet and Liquidity - As of September 30, 2025, the company had cash, restricted cash, and short-term investments totaling $84.4 million, down from $133.4 million the previous year [9][10]. - Total assets increased by 37% to $562.2 million, while total liabilities rose by 109% to $213.1 million [10][9]. Future Outlook - The company anticipates strong revenue growth in Fiscal 2026, with net revenue expected to exceed $300 million, supported by increasing domestic and international demand [7][4].

No age group is taking up cannabis faster https://t.co/LdXBqdnjiE ...

Turkey isn't the only thing getting baked this Thanksgiving. Turns out today has become one of the biggest cannabis sale holidays of the year. Behind only April 20th, of course, that's 420.And this year, the industry is really cooking. I checked in with some popular brands. THC infused beverage maker can tells me November typically brings in a 40% month-over-month sales jump and that this year they're already pacing to beat that.Nowadays, another brand also seeing the holiday bump. Last November, sales spik ...

Well, move over Black Friday. Cannabis has carved out its own holiday shopping rush and it's called Green Wednesday. Our Brandon Gomez joins us with that story.Brandon, we were talking about this hit in advance and it kind of makes some sense. Hey, Carl. Yeah, that's right.We've been talking about the trend, but look, turkey isn't the only thing getting baked this Thanksgiving. Turns out today has become one of the biggest cannabis sale holidays of the year. Behind only April 20th, of course, that's 420.And ...